Literature DB >> 31915139

Serum amyloid A is not incorporated into HDL during HDL biogenesis.

Ailing Ji1, Xuebing Wang1, Victoria P Noffsinger1, Drew Jennings2, Maria C de Beer1,3, Frederick C de Beer1,4, Lisa R Tannock1,4, Nancy R Webb5,6.   

Abstract

Liver-derived serum amyloid A (SAA) is present in plasma where it is mainly associated with HDL and from which it is cleared more rapidly than are the other major HDL-associated apolipoproteins. Although evidence suggests that lipid-free and HDL-associated forms of SAA have different activities, the pathways by which SAA associates and disassociates with HDL are poorly understood. In this study, we investigated SAA lipidation by hepatocytes and how this lipidation relates to the formation of nascent HDL particles. We also examined hepatocyte-mediated clearance of lipid-free and HDL-associated SAA. We prepared hepatocytes from mice injected with lipopolysaccharide or an SAA-expressing adenoviral vector. Alternatively, we incubated primary hepatocytes from SAA-deficient mice with purified SAA. We analyzed conditioned media to determine the lipidation status of endogenously produced and exogenously added SAA. Examining the migration of lipidated species, we found that SAA is lipidated and forms nascent particles that are distinct from apoA-I-containing particles and that apoA-I lipidation is unaltered when SAA is overexpressed or added to the cells, indicating that SAA is not incorporated into apoA-I-containing HDL during HDL biogenesis. Like apoA-I formation, generation of SAA-containing particles was dependent on ABCA1, but not on scavenger receptor class B type I. Hepatocytes degraded significantly more SAA than apoA-I. Taken together, our results indicate that SAA's lipidation and metabolism by the liver is independent of apoA-I and that SAA is not incorporated into HDL during HDL biogenesis.
Copyright © 2020 Ji et al.

Entities:  

Keywords:  adenosine 5′-triphosphate binding cassette transporter A1; hepatocyte; inflammatory disease; lipid metabolism; lipidation; lipoprotein; liver metabolism; nascent high density lipoprotein

Year:  2020        PMID: 31915139      PMCID: PMC7053844          DOI: 10.1194/jlr.RA119000329

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  52 in total

1.  Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.

Authors:  M C de Beer; D M Durbin; L Cai; N Mirocha; A Jonas; N R Webb; F C de Beer; D R van Der Westhuyzen
Journal:  J Biol Chem       Date:  2001-02-09       Impact factor: 5.157

2.  Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.

Authors:  Nicholas M Frame; Olga Gursky
Journal:  Amyloid       Date:  2016-12-31       Impact factor: 7.141

3.  SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.

Authors:  V G Cabana; C A Reardon; B Wei; J R Lukens; G S Getz
Journal:  J Lipid Res       Date:  1999-06       Impact factor: 5.922

4.  Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and γδ T cells.

Authors:  Desiree Anthony; Huei Jiunn Seow; Mohib Uddin; Michelle Thompson; Lovisa Dousha; Ross Vlahos; Louis B Irving; Bruce D Levy; Gary P Anderson; Steven Bozinovski
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

5.  Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions.

Authors:  T Yamada; T Kakihara; T Kamishima; T Fukuda; T Kawai
Journal:  Pathol Int       Date:  1996-10       Impact factor: 2.534

Review 6.  Serum amyloid A and atherosclerosis.

Authors:  Godfrey S Getz; Paulette A Krishack; Catherine A Reardon
Journal:  Curr Opin Lipidol       Date:  2016-10       Impact factor: 4.776

7.  The acute phase response in apolipoprotein A-1 knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins.

Authors:  T Hajri; R Elliott-Bryant; J D Sipe; J S Liang; K C Hayes; E S Cathcart
Journal:  Biochim Biophys Acta       Date:  1998-11-02

Review 8.  Serum amyloid A: an acute-phase protein involved in tumour pathogenesis.

Authors:  E Malle; S Sodin-Semrl; A Kovacevic
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

9.  Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study.

Authors:  Carola Marzi; Cornelia Huth; Christian Herder; Jens Baumert; Barbara Thorand; Wolfgang Rathmann; Christa Meisinger; H-Erich Wichmann; Michael Roden; Annette Peters; Harald Grallert; Wolfgang Koenig; Thomas Illig
Journal:  Diabetes Care       Date:  2012-12-13       Impact factor: 19.112

Review 10.  Serum amyloid A - a review.

Authors:  George H Sack
Journal:  Mol Med       Date:  2018-08-30       Impact factor: 6.354

View more
  4 in total

1.  Human Serum Amyloid a Impaired Structural Stability of High-Density Lipoproteins (HDL) and Apolipoprotein (Apo) A-I and Exacerbated Glycation Susceptibility of ApoA-I and HDL.

Authors:  Kyung-Hyun Cho
Journal:  Molecules       Date:  2022-07-01       Impact factor: 4.927

Review 2.  High-Density Lipoproteins and Serum Amyloid A (SAA).

Authors:  Nancy R Webb
Journal:  Curr Atheroscler Rep       Date:  2021-01-15       Impact factor: 5.113

Review 3.  Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.

Authors:  Olga Gursky
Journal:  Curr Atheroscler Rep       Date:  2020-09-24       Impact factor: 5.113

4.  HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study.

Authors:  Bianca Papotti; Chiara Macchi; Chiara Favero; Simona Iodice; Maria Pia Adorni; Francesca Zimetti; Alberto Corsini; Stefano Aliberti; Francesco Blasi; Stefano Carugo; Valentina Bollati; Marco Vicenzi; Massimiliano Ruscica
Journal:  J Clin Med       Date:  2021-12-18       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.